ARCA biopharma

$4.69
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (+0.22%) Today

+$0.03 (+0.64%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ARCA biopharma and other stocks, options, and ETFs commission-free!

About ABIO

ARCA biopharma, Inc. Common Stock, also called ARCA biopharma, is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company engages in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, Gencaro is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO. The listed name for ABIO is ARCA biopharma, Inc. Common Stock.

CEO

Michael R. Bristow

Employees

Headquarters

Westminster, Colorado

Founded

1992

Market Cap

43.06M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

705.26K

High Today

$4.75

Low Today

$4.59

Open Price

$4.69

Volume

807.42K

52 Week High

$22.00

52 Week Low

$2.21

Collections

ABIO Earnings

-$1.14

-$0.76

-$0.38

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 16, Pre-Market